Drug
Vilaprisan clinical trials
Also written BAY1002670.
- studies test it
- 16
- open now
- 0
- in phase 3
- 6
- first study started
- 2011
How studies write it
Studies that test it under each name
Name
Development codes
Studies by the year they started
16 studies that test it; most in 2018 (6)
| Year | Studies |
|---|---|
| 2011 | 1 |
| 2014 | 2 |
| 2015 | 2 |
| 2017 | 5 |
| 2018 | 6 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 7
- Phase 2
- 3
- Phase 3
- 6
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 16 · Other 0
Studies
Open first, then newest update. How each study uses vilaprisan is read from its arms, and is right about nine times in ten.
Testing it · 16
- Assess Safety and Efficacy of Vilaprisan in Subjects With Uterine FibroidsTerminatedPhase 3BayerNCT03194646Written as Vilaprisan (BAY1002670)
- A Study to Assess Safety and Efficacy of Vilaprisan in Subjects With Uterine FibroidsTerminatedPhase 3BayerNCT03240523Written as Vilaprisan (BAY1002670)
- Assess Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids (ASTEROID 3)TerminatedPhase 3BayerNCT03400943Written as Vilaprisan (BAY1002670)
- A Study to Assess the Safety and Efficacy of Vilaprisan in Japanese Subjects With Uterine Fibroids and Heavy Menstrual BleedingTerminatedPhase 3BayerNCT03476928Written as Vilaprisan (BAY1002670)
- Assess Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids (ASTEROID 4)TerminatedPhase 3BayerNCT03400956Written as Vilaprisan (BAY1002670)
- Assess Safety and Efficacy of Vilaprisan in Subjects With EndometriosisTerminatedPhase 2BayerNCT03573336Written as Vilaprisan (BAY1002670)
- Mode of Action Study of Vilaprisan and Ulipristal Acetate in Patients With Uterine Fibroids for Whom Surgery is PlannedTerminatedPhase 1BayerNCT03342859Written as Vilaprisan, BAY1002670
- Assessment of Safety and Efficacy of Vilaprisan in Subjects With Uterine FibroidsWithdrawnPhase 3BayerNCT03699176Written as Vilaprisan (BAY1002670)
- Pharmacokinetics and Safety of Vilaprisan in Renal ImpairmentCompletedPhase 1BayerNCT03411980Written as Vilaprisan (BAY1002670)
- Drug-drug Interaction Study: Influence of Vilaprisan on Pharmacodynamics (PD) and Pharmacokinetics (PK) of a Combined Oral Contraceptive (COC)CompletedPhase 1BayerNCT03210246Written as Vilaprisan (BAY 1002670)
- Bay1002670, Fibroids, Safety and Efficacy EU,US,Can, JapCompletedPhase 2BayerNCT02131662Written as BAY1002670
- Effect of Hepatic Impairment on the Pharmacokinetics, Safety and Tolerability of BAY1002670 (Vilaprisan)CompletedPhase 1BayerNCT03092999Written as Vilaprisan (BAY1002670)
- Assess Safety and Efficacy of Vilaprisan in Patients With Uterine FibroidsCompletedPhase 2BayerNCT02465814Written as Vilaprisan (BAY1002670)
- Study in Healthy Young Women to Investigate the Pharmacodynamics, Pharmacokinetics and Safety of VilaprisanCompletedPhase 1BayerNCT02262663Written as Vilaprisan (BAY1002670)
- Study in Postmenopausal Women to Investigate the Drug-drug Interaction (DDI) Between Itraconazole(ITZ) and Orally Administered Vilaprisan; Absolute Bioavailability Using Intravenous Microtracer Dose of [14C]VilaprisanCompletedPhase 1BayerNCT02456129Written as Vilaprisan (BAY1002670)
- Study in Healthy Tubal Ligated Women to Evaluate Pharmacodynamics, Safety and Pharmacokinetics of BAY1002670CompletedPhase 1BayerNCT01816815Written as BAY1002670
Codes
What other systems call vilaprisan · ClinicalTrials.gg INT006440
- UNII (FDA) IN59K53GI9VILAPRISANConfirmed FDA, Wikidata
- Wikidata Q27280805vilaprisanConfirmed FDA, Wikidata
- NCI Thesaurus C148505VilaprisanOne source FDA
- DrugBank DB11971One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | IN59K53GI9 | VILAPRISAN | Confirmed FDA, Wikidata |
| Wikidata | Q27280805 | vilaprisan | Confirmed FDA, Wikidata |
| NCI Thesaurus | C148505 | Vilaprisan | One source FDA |
| DrugBank | DB11971 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.